[Arterin - a nutritional supplement in the treatment of dyslipidemia: results of a short-term clinical follow-up study]

Vnitr Lek. 2016 Fall;62(10):837-840.
[Article in Czech]


Elevated LDL-cholesterol levels are among the main risk factors for ischemic heart disease. It can be influenced by pharmacotherapy, but also by changes in eating and life habits. The most recent recommendations on the treatment of dyslipidemia devote special attention to nutritional supplements and functional foods.Key words: arterin (monacolin K) - dyslipidemia - cardiovascular complications - lipid spectrum.

Publication types

  • Clinical Study

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol, LDL / blood
  • Dietary Supplements
  • Dyslipidemias / blood
  • Dyslipidemias / drug therapy*
  • Follow-Up Studies
  • Humans
  • International Cooperation
  • Lovastatin / therapeutic use*
  • Myocardial Ischemia
  • Risk Factors


  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Lovastatin